Literature DB >> 6807397

Acquired inhibitor to human factor VIII associated with paraproteinaemia and subsequent development of chronic lymphatic leukaemia.

P R Kelsey, M J Leyland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6807397      PMCID： PMC1499400          DOI： 10.1136/bmj.285.6336.174

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Acquired factor VIII inhibitor in a patient with malignant lymphoma.

Authors:  B Wenz; G Friedman
Journal:  Am J Med Sci       Date:  1974-11       Impact factor: 2.378

2.  A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillin.

Authors:  H I Glueck; R Hong
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

3.  An eleven-year follow-up on 64 subjects with M-components.

Authors:  U Axelsson
Journal:  Acta Med Scand       Date:  1977
  3 in total
  3 in total

1.  Acquired hemophilia in a patient with myeloma.

Authors:  L S Loftus; W N Arnold
Journal:  West J Med       Date:  1994-02

Review 2.  Varied immune response to FVIII: presence of proteolytic antibodies directed to factor VIII in different human pathologies.

Authors:  Bharath Wootla; Desirazu Narasimha Rao; Narasimha Rao Desirazu; Alain Friboulet; Taizo Uda; Sébastien Lacroix-Desmazes; Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

3.  Successful Treatment of Factor X Deficiency in a Patient with Lymphoplasmacytic Lymphoma with Bendamustine Plus Rituximab Regimen: A Case Report and Literature Review.

Authors:  Tarinee Rungjirajittranon; Yingyong Chinthammitr; Chattree Hantaweepant
Journal:  J Blood Med       Date:  2021-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.